Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies-Reference-Cited by-同舟云学术

Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies

Published:2015-08-17 Issue:10 Volume:47 Page:1131-1140
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Saliba Joseph,Saint-Martin Cécile,Di Stefano Antonio,Lenglet Gaëlle,Marty Caroline,Keren Boris,Pasquier Florence,Valle Véronique Della,Secardin Lise,Leroy Gwendoline,Mahfoudhi Emna,Grosjean Sarah,Droin Nathalie,Diop M'boyba,Dessen Philippe,Charrier Sabine,Palazzo Alberta,Merlevede Jane,Meniane Jean-Côme,Delaunay-Darivon Christine,Fuseau Pascal,Isnard Françoise,Casadevall Nicole,Solary Eric,Debili Najet,Bernard Olivier A,Raslova Hana,Najman Albert,Vainchenker William,Bellanné-Chantelot Christine,Plo Isabelle

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3380.pdf

Reference62 articles.

1. Song, W.J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23, 166–175 (1999).

2. Smith, M.L., Cavenagh, J.D., Lister, T.A. & Fitzgibbon, J. Mutation of CEBPA in familial acute myeloid leukemia. N. Engl. J. Med. 351, 2403–2407 (2004).

3. Hahn, C.N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012–1017 (2011).

4. Pasquet, M. et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121, 822–829 (2013).

5. Bluteau, D. et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J. Clin. Invest. 124, 580–591 (2014).

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes;Leukemia Research;2024-08

2. Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms;Frontiers in Oncology;2024-07-16

3. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk;Blood Cancer Journal;2024-01-15

4. Germline Predisposition in Hematologic Malignancies;Comprehensive Hematology and Stem Cell Research;2024

5. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10